Patent US5162303A successfully refreshed from Google Patents.
US5162303A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Pharmaceutical compositions containing prolactin and methods for the use thereof
Assignee: Amiad Research and Development
•
Filing: 1990-10-04
•
Granted: 1992-11-10
•
Expires: 2010-10-04
Abstract
Abstract The invention provides a pharmaceutical composition for increasing the tensile strength of connective tissue while modifying the amount of cross-linked collagen therein comprising prolactin in an amount effective to increase the tensile strength of connective tissue as active ingredient therein in combination with a pharmacologically acceptable carrier.
Inventors
- 👤 Geoffrey Goodman
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-27 19:56
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/22; A61K38/2257; A61K31/00; A61K31/33; A61K31/335; A61K31/365; A61K31/375
Claims Analysis
Total Claims: 21
Claim 1
Independent Claim
42 words
A pharmaceutical composition comprising an effective amount of prolactin; ascorbic acid or an ascorbate; and a pharmacologically acceptable carrier; wherein the amounts of prolactin and ascorbic acid or ascorbate are effective to modify the amount of Type III collagen in connective tissue.
Claim 2
Dependent Claim
42 words
A pharmaceutical composition comprising an effective amount of prolactin; ascorbic acid or an ascorbate; and a pharmacologically acceptable carrier; wherein the amounts of prolactin and ascorbic acid or ascorbate are effective to modify the amount of Type III collagen in connective tissue.
Claim 3
Dependent Claim
14 words
A pharmaceutical composition according to claim 3 wherein the composition is in topical form.
Claim 4
Dependent Claim
18 words
A pharmaceutical composition according to claim 3 wherein said active ingredient and carrier are formulated for internal administration.
Claim 5
Dependent Claim
18 words
A pharmaceutical composition according to claim 3 wherein said connective tissue is connective tissue of the skeletal system.
Claim 6
Dependent Claim
15 words
A pharmaceutical composition according to claim 3 wherein said connective tissue is cardiovascular connective tissue.
Claim 7
Dependent Claim
18 words
A pharmaceutical composition according to claim 3 wherein said connective tissue is connective tissue of the gastrointestinal tract.
Claim 8
Dependent Claim
37 words
A pharmaceutical composition comprising an effective amount of prolactin; ascorbic acid or an ascorbate; and a pharmacologically acceptable carrier; wherein the amounts of prolactin and ascorbic acid or ascorbate are effective for promoting wound and tissue healing.
Claim 9
Dependent Claim
37 words
A pharmaceutical composition comprising an effective amount of prolactin; ascorbic acid or an ascorbate; and a pharmacologically acceptable carrier; wherein the amounts of prolactin and ascorbic acid or ascorbate are effective for promoting wound and tissue healing.
Claim 10
Dependent Claim
18 words
A pharmaceutical composition according to claim 7 wherein said active ingredient and carrier are formulated for internal administration.
Claim 11
Dependent Claim
18 words
A pharmaceutical composition according to claim 7 wherein said connective tissue is connective tissue of the gastrointestinal tract.
Claim 12
Dependent Claim
50 words
A pharmaceutical composition comprising an effective amount of a combination of prolactin and ascorbic acid or prolactin and an ascorbate as active ingredients therein, together with a pharmacologically acceptable carrier wherein the amounts of prolactin and ascorbic acid or ascorbate are effective to increase the tensile strength of connective tissue.
Claim 13
Dependent Claim
50 words
A pharmaceutical composition comprising an effective amount of a combination of prolactin and ascorbic acid or prolactin and an ascorbate as active ingredients therein, together with a pharmacologically acceptable carrier wherein the amounts of prolactin and ascorbic acid or ascorbate are effective to increase the tensile strength of connective tissue.
Claim 14
Dependent Claim
18 words
A pharmaceutical composition according to claim 17 wherein said active ingredient and carrier are formulated for internal administration.
Claim 15
Dependent Claim
18 words
A pharmaceutical composition according to claim 17 wherein said connective tissue is connective tissue of the gastrointestinal tract.
Claim 16
Independent Claim
46 words
A method for protecting and restoring skin connective tissue in a mammalian or avian species comprising applying a topical cosmetic composition comprising prolactin in an amount effective to increase the tensile strength of connective tissue as active ingredient therein in combination with a pharmacologically acceptable carrier.
Claim 17
Independent Claim
46 words
A method for protecting and restoring skin connective tissue in a mammalian or avian species comprising applying a topical cosmetic composition comprising prolactin in an amount effective to increase the tensile strength of connective tissue as active ingredient therein in combination with a pharmacologically acceptable carrier.
Claim 18
Independent Claim
51 words
A method for protecting and restoring connective tissue in a mammalian or avian species comprising internally administering to said mammalian or avian species a pharmaceutical composition comprising prolactin in an amount effective to increase the tensile strength of connective tissue as active ingredient therein in combination with a pharmacologically acceptable carrier.
Claim 19
Independent Claim
51 words
A method for protecting and restoring connective tissue in a mammalian or avian species comprising internally administering to said mammalian or avian species a pharmaceutical composition comprising prolactin in an amount effective to increase the tensile strength of connective tissue as active ingredient therein in combination with a pharmacologically acceptable carrier.
Claim 20
Independent Claim
48 words
A method for increasing the tensile strength of connective tissue in a mammalian or avian species comprising administering to said mammalian or avian species a pharmaceutical composition containing an effective amount of a combination of prolactin and ascorbic acid or prolactin and an ascorbate as active ingredients therein.
Claim 21
Independent Claim
48 words
A method for increasing the tensile strength of connective tissue in a mammalian or avian species comprising administering to said mammalian or avian species a pharmaceutical composition containing an effective amount of a combination of prolactin and ascorbic acid or prolactin and an ascorbate as active ingredients therein.
References Cited (Backward Citations)
DE1144263B
Cited
US3887705A
Cited
JPS5714587A
Cited
EP0046409A1
Cited
JPS58222078A
Cited
US4668516A
Cited
US4959358A
Cited
US4695452A
Cited
US4954298A
Cited
JPS62207289A
Cited
US4882359A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-11-10 | 1996-05-11 | 1996-11-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-11-10 | 2000-05-11 | 2000-11-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-11-10 | 2004-05-11 | 2004-11-10 | $7700.00 | Window Closed / Lapsed |